Direxion Daily S&P Biotech Bull 3X ETF
LABU
12 hedge funds and large institutions have $7.27M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
434% more capital invested
Capital invested by funds: $1.36M → $7.27M (+$5.91M)
109% more call options, than puts
Call options by funds: $4.29M | Put options by funds: $2.05M
100% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 4
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
50% more funds holding
Funds holding: 8 → 12 (+4)
0.03% more ownership
Funds ownership: 0.03% → 0.05% (+0.03%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$1.31M |
| 2 |
Jane Street
New York
|
+$1.21M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.14M |
| 4 |
TCM
Traynor Capital Management
Malvern,
Pennsylvania
|
+$1.11M |
| 5 |
BHA
Beech Hill Advisors
New York
|
+$727K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$243K |
| 2 |
OPPM
Opus Point Partners Management
New York
|
-$241K |
| 3 |
Morgan Stanley
New York
|
-$8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.48K |
| 5 |
TWA
TCI Wealth Advisors
Tucson,
Arizona
|
-$1K |
LABU Hedge Fund Activity: Q4 2015 in Review
12 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q4 2015, worth a combined $7.27M — up 434% from $1.36M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new LABU positions and 4 closed out — a net gain of 4 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $1.31M. The largest seller was Susquehanna International Group, exiting entirely with an estimated $243K sold.
- 12 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q4 2015, up from 8 in Q3 2015.
- Funds reported $7.27M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q4 2015, up 434% quarter-over-quarter.
- 8 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q4 2015 and 4 closed out, a net change of +4 holders.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q4 2015 was Virtu Financial, an estimated $1.31M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q4 2015 was Susquehanna International Group, an estimated $243K sold.
Based on aggregated 13F filings for Q4 2015.